glp-1 news 2025 october 9 Looming drug patent expirations draw generics firms glp-1 news october 9 2025

David Shafer explains why volume loss appears, what helps, and when fillers may work.

Learn the benefits of this treatment and book your consultation at Unicorn Medispa today!

Descubre cmo los medicamentos GLP-1 despus de ciruga baritrica ayudan a recuperar peso perdido

That might show up as a great result on the scale, but it leaves people metabolically weaker, not stronger

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course